全文获取类型
收费全文 | 6350篇 |
免费 | 356篇 |
国内免费 | 27篇 |
专业分类
耳鼻咽喉 | 27篇 |
儿科学 | 94篇 |
妇产科学 | 88篇 |
基础医学 | 643篇 |
口腔科学 | 90篇 |
临床医学 | 731篇 |
内科学 | 1728篇 |
皮肤病学 | 385篇 |
神经病学 | 696篇 |
特种医学 | 177篇 |
外科学 | 643篇 |
综合类 | 15篇 |
一般理论 | 1篇 |
预防医学 | 540篇 |
眼科学 | 44篇 |
药学 | 456篇 |
中国医学 | 5篇 |
肿瘤学 | 370篇 |
出版年
2024年 | 5篇 |
2023年 | 30篇 |
2022年 | 93篇 |
2021年 | 210篇 |
2020年 | 131篇 |
2019年 | 199篇 |
2018年 | 247篇 |
2017年 | 171篇 |
2016年 | 157篇 |
2015年 | 167篇 |
2014年 | 270篇 |
2013年 | 342篇 |
2012年 | 485篇 |
2011年 | 497篇 |
2010年 | 310篇 |
2009年 | 256篇 |
2008年 | 382篇 |
2007年 | 372篇 |
2006年 | 377篇 |
2005年 | 373篇 |
2004年 | 328篇 |
2003年 | 286篇 |
2002年 | 278篇 |
2001年 | 82篇 |
2000年 | 76篇 |
1999年 | 82篇 |
1998年 | 53篇 |
1997年 | 42篇 |
1996年 | 39篇 |
1995年 | 43篇 |
1994年 | 27篇 |
1993年 | 12篇 |
1992年 | 26篇 |
1991年 | 36篇 |
1990年 | 37篇 |
1989年 | 36篇 |
1988年 | 29篇 |
1987年 | 22篇 |
1986年 | 21篇 |
1985年 | 13篇 |
1984年 | 10篇 |
1981年 | 8篇 |
1980年 | 4篇 |
1979年 | 9篇 |
1977年 | 7篇 |
1974年 | 5篇 |
1973年 | 5篇 |
1972年 | 6篇 |
1971年 | 8篇 |
1960年 | 3篇 |
排序方式: 共有6733条查询结果,搜索用时 15 毫秒
41.
Nerea Becerra-Tomás Andrés Díaz-López Núria Rosique-Esteban Emilio Ros Pilar Buil-Cosiales Dolores Corella Ramon Estruch Montserrat Fitó Lluís Serra-Majem Fernando Arós Rosa Maria Lamuela-Raventós Miquel Fiol José Manuel Santos-Lozano Javier Díez-Espino Olga Portoles Jordi Salas-Salvadó 《Clinical nutrition (Edinburgh, Scotland)》2018,37(3):906-913
42.
43.
Del Llano Juan Mestre-Ferrandiz Jorge Espin Jaime Gol-Montserrat Jordi del Llano Alicia Bringas Carlos 《The European journal of health economics》2022,23(3):329-335
The European Journal of Health Economics - 相似文献
44.
M.Q. Gorgas Torner F. Pàez Vives J. Camós Ramió E. de Puig Cabrera P. Jolonch Santasusagna E. Homs Peipoch J.A. Schoenenberger Arnaiz C. Codina Jané J. Gómez-Arbonés 《Farmacia hospitalaria》2012,36(4):229-239
ObjectivesTo assess whether an integrated pharmaceutical care programme (IPCP) improves clinical evolution, patient quality of life, and reduces health costs in chronic patients.Material and methodsA parallel, open, and multi-centre clinical trial of an IPCP in patients with heart failure (HF) and/or chronic obstructive pulmonary disease (COPD) in 8 different health areas in Cataluña. The intervened patient was monitored for pharmacotherapeutic evolution by hospital pharmacists, primary care physicians, and community pharmacists. Controls received normal follow-up. All patients were monitored for 12 months, with quality of life tests administered at the beginning and end of follow-up.ResultsWe had the participation of 8 different hospitals, 8 primary care centres, and 109 community pharmacies. 238 patients completed the study, with 2.9% of participants lost during the study period. There were no significant differences in terms of readmissions, visits to the doctors, or to emergency services. We detected 50 different medication-related problems (MRP) in 37 patients, with a statistically significant difference in terms of MRP between the control and treatment groups of patients with HF, and almost significant differences in COPD patients. MRP were moderate-severe in 36% of cases. MRP were avoidable in 94% of cases, and the pharmacist resolved the issue in 90% of cases. There were no differences in terms of patient quality of life or health costs between the start and end of the study.ConclusionsIntegrated pharmaceutical care programs facilitate an improvement in the quality of patient care, but electronic registries are necessary to promote communication between sections of the health care network. 相似文献
45.
46.
Ke Zheng Jordi Xiol Michael Reuter Sigrid Eckardt N. Adrian Leu K. John McLaughlin Alexander Stark Ravi Sachidanandam Ramesh S. Pillai Peijing Jeremy Wang 《Proceedings of the National Academy of Sciences of the United States of America》2010,107(26):11841-11846
Piwi-interacting RNAs (piRNAs) are essential for silencing of transposable elements in the germline, but their biogenesis is poorly understood. Here we demonstrate that MOV10L1, a germ cell–specific putative RNA helicase, is associated with Piwi proteins. Genetic disruption of the MOV10L1 RNA helicase domain in mice renders both MILI and MIWI2 devoid of piRNAs. Absence of a functional piRNA pathway in Mov10l1 mutant testes causes loss of DNA methylation and subsequent derepression of retrotransposons in germ cells. The Mov10l1 mutant males are sterile owing to complete meiotic arrest. This mouse mutant expresses Piwi proteins but lacks piRNAs, suggesting that MOV10L1 is required for piRNA biogenesis and/or loading to Piwi proteins. 相似文献
47.
Francisco J. Padillo Juan F. Ruiz‐Rabelo Adolfo Cruz María D. Perea Inmaculada Tasset Pedro Montilla Isaac Túnez Jordi Muntané 《Journal of pineal research》2010,49(3):264-270
Abstract: Pancreatic cancer is a major health problem because of the aggressiveness of the disease and the lack of effective systemic therapies. Melatonin (MEL) has antioxidant activity and prevents experimental genotoxicity. The specific inhibitor of cyclooxygenase‐2 (COX‐2), celecoxib (CEL), increases the efficacy of chemoradiotherapy in advanced pancreatic cancer. The objective of the study was the comparison and synergic effect of MEL and CEL during either the induction or progression phases of the tumor process, measuring parameters of oxidative stress, number of tumor nodules and survival of animals with pancreatic cancer. Pancreatic cancer was induced by N‐nitrosobis (2‐oxopropyl)amine) (BOP) in Syrian hamsters. Melatonin and/or CEL were administered during the induction, postinduction as well as during both phases. The presence of tumor nodules were observed macroscopically in pancreatic and splenic areas, and the levels of lipoperoxides (LPO), reduced glutathione (GSH), superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GSH‐Px) in pancreatic tissue were measured. The increases in tumor nodules and LPO as well as the reductions in GSH and enzymatic antioxidants in the pancreas induced by BOP were related to a lower survival rate of animals. The administration of MEL exerted a more potent beneficial effect than CEL treatment on the reduction in tumor nodules, oxidative stress and death of experimental BOP‐treated animals. The combined treatment only exerted a synergistic beneficial effect when administered during the induction phase. Melatonin by itself had significant beneficial actions in improving the survival of hamsters. 相似文献
48.
49.
Peran L Camuesco D Comalada M Nieto A Concha A Diaz-Ropero MP Olivares M Xaus J Zarzuelo A Galvez J 《World journal of gastroenterology : WJG》2005,11(33):5185-5192
AIM: To investigate the intestinal anti-inflammatory effect and mechanism of a probiotic Lactobacillus salivarius ssp. salivarius CECT5713 in the TNBS model of rat colitis. METHODS: Female Wistar rats (180-200 g) were used in this study. A group of rats were administered orally the probiotic L. salivarius ssp. salivarius(5×108 CFU suspended in 0.5 mL of skimmed milk) daily for 3 wk. Two additional groups were used for reference, a non-colitic and a control colitic without probiotic treatment, which received orally the vehicle used to administer the probiotic. Two weeks after starting the experiment, the rats were rendered colitic by intracolonic administration of 10 mg of TNBS dissolved in 0.25 mL of 500 mL/L ethanol. One week after colitis induction, all animals were killed and colonic damage was evaluated both histologically and biochemically. The biochemical studies performed in colonic homogenates include determination of myeloperoxidase (MPO) activity, glutathione (GSH) content, leukotriene B4 (LTB4) and tumor necrosis factor a (TNF-α) levels, as well as inducible nitric oxide synthase (iNOS) expression. In addition, the luminal contents obtained from colonic samples were used for microbiological studies, in order to determine Lactobacilli and Bifidobacteria counts. RESULTS: Treatment of colitic rats with L salivarius ssp. salivarius resulted in amelioration of the inflammatory response in colitic rats, when compared with the corresponding control group without probiotic treatment. This anti-inflammatory effect was evidenced macroscopically by a significant reduction in the extent of colonic necrosis and/or inflammation induced by the administration of TNBS/ethanol (2.3±0.4 cm vs 53.4±0.3 cm in control group, P<0.01) and histologically by improvement of the colonic architecture associated with a reduction in the neutrophil infiltrate in comparison with non-treated colitic rats. The latter was confirmed biochemically by a significant reduction of colonic MPO activity (105.3±26.0 U/g vs 180.6±21.9 U/g, P<0.05) a marker of neutrophil infiltration. The beneficial effect was associated with an increase of the colonic GSH content (1 252±42 nmol/g vs 1 087±51 nmol/g,P<0.05), which is depleted in colitic rats, as a consequence of the oxidative stress induced by the inflammatory process. In addition, the treatment of colitic rats with L. salivarius resulted in a significant reduction of colonic TNF-α levels (509.4±68.2 pg/g vs 782.9±60.1 pg/g, P<0.01) and in a lower colonic iNOS expression, when compared to TNBS control animals without probiotic administration. Finally, treated colitic rats showed higher counts of Lactobacilli species in colonic contents than control colitic rats, whereas no differences were observed in Bifidobacteria counts. CONCLUSION: Administration of the probiotic L. salivarius ssp. salivarius CECT5713 facilitates the recovery of the inflamed tissue in the TNBS model of rat colitis, an effect associated with amelioration of the production of some of the mediators involved in the inflammatory response in the intestine, such as cytokines, including TNF-α and NO. This beneficial effect could be ascribed to its effect on the altered immune response that occurs in this inflammatory condition. 相似文献
50.
Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. 总被引:26,自引:0,他引:26
Javier Fernández Miquel Navasa Juliá Gómez Jordi Colmenero Jordi Vila Vicente Arroyo Juan Rodés 《Hepatology (Baltimore, Md.)》2002,35(1):140-148
The extensive use of invasive procedures and of long-term norfloxacin prophylaxis in the management of cirrhotic patients may have influenced the epidemiology of bacterial infections in cirrhosis. We conducted a prospective evaluation of all bacterial infections diagnosed in patients with cirrhosis in a Liver Unit between April 1998 and April 2000. A total of 405 patients presented 572 bacterial infections in 507 admissions. Spontaneous bacterial peritonitis was the most frequent infection (138 cases). Gram-positive cocci were responsible for 53% of total bacterial infections in the study, being the main bacteria isolated in nosocomial infections (59%). Patients requiring treatment in an intensive care unit and those submitted to invasive procedures presented a higher rate of infections caused by gram-positive cocci (77% vs. 48%, P <.001 and 58% vs. 40%, P <.02, respectively). Fifty percent of culture-positive spontaneous bacterial peritonitis in patients on long-term norfloxacin administration (n = 93) and 16% in patients not receiving this therapy (n = 414) were caused by quinolone-resistant gram-negative bacilli, P =.01. The rate of culture-positive spontaneous bacterial peritonitis caused by trimethoprim-sulfamethoxazole-resistant gram-negative bacilli was also very high in patients on long-term norfloxacin administration (44% vs. 18%, P =.09). In conclusion, infections caused by gram-positive cocci have markedly increased in cirrhosis. This phenomenon may be related to the current high degree of instrumentation of cirrhotic patients. Quinolone-resistant spontaneous bacterial peritonitis constitutes an emergent problem in patients on long-term norfloxacin prophylaxis, with trimethoprim-sulfamethoxazole not being a valid alternative. 相似文献